Brazilian Agitation Guidance: Route and Monitoring Matter in Benzodiazepine Review

The supplied Brazilian guideline treats drug selection, administration route, and observation as linked parts of managing psychomotor agitation.

What the guideline evaluated

The working group reviewed 85 articles and considered heterogeneous causes of agitation, medication choices, and outcomes. Its conclusions favored nonpharmacological measures first, oral treatment where feasible, selection based on cause and contraindications, and monitoring before and after medication. Benzodiazepines were among the pharmacological options considered.

Using guidance without overstating it

The authors acknowledged that different drugs, doses, scales, and definitions of success made comparisons difficult. Their recommendations reflect an evidence synthesis and professional interpretation within a particular practice setting, rather than a universal demonstration that one route or agent is always appropriate. Reviewing an episode therefore requires the indication, cooperation level, co-exposures, administration route, and monitoring record. Calmness, sleep, and resolution of the cause of agitation are different endpoints; a sedated patient has not necessarily had the underlying condition treated.

Source paper

Original analysis of the supplied journal article, identified as PMC6804299.

Related research

• Benzodiazepine Withdrawal Belongs in the Differential for Catatonia, but a Review Cannot Diagnose the Case
• Pediatric Emergence-Agitation Comparison Also Changed Route of Premedication